Following misleading information in the public domain, it was clarified at the meetings of WADA’s Executive Committee and Foundation Board on November 19-20 that there is no consideration of abandoning the current doping control procedure which allows an athlete whose A-sample has revealed the presence of a prohibited substance or method to request the analysis of his or her B-sample.
“The B-sample helps confirm that an anti-doping rule violation has occurred and protects the rights of the athletes,” said WADA Director General David Howman. “It should be stressed that anti-doping is one of the few types of controls in society in which a confirmation procedure is used in order to protect individuals, and the very rare cases in which the analysis of the B-sample did not match the results of the A-sample have shown the usefulness of such procedure.”
As part of the ongoing revision of the World Anti-Doping Code (Code)—the core document that provides the framework for harmonized anti-doping policies, rules and regulations within sport organizations and among public authorities—a number of stakeholders have suggested considering anti-doping rule violations on the basis of one sample if other available evidence demonstrates to the satisfaction of the panel that the athlete was doping.
The first draft of the revised Code will be sent to stakeholders and published in January 2007 for the second of three phases of consultation. This consultation will culminate at the Third World Conference on Doping in Sport, to be held November 15-17 in Madrid, Spain.
Click here for more information on the Code review and consultation.